Gamgee
Using ChatGPT and AlphaFold to design personalized mRNA cancer vaccines for dogs, with clinical trials underway
Home › AI Use-Case Library › AI in Pharma & Biotech: 5 real deployments
AI in Pharma & Biotech: 5 real deployments
Named Pharma & Biotech organisations and what they run, grouped by business function.
5deployments
1in production or with results
0with a reported outcome
0halted or reversed
Aug 30, 2026last updated
R&D & discovery 4 deployments
Eli Lilly
Eli Lilly runs AI-driven drug discovery at pharma scale on dedicated supercomputing infrastructure under Chief AI Officer Thomas Fuchs.
Amgen, Moderna, Allen Institute, Thermo Fisher
Amgen, Moderna, the Allen Institute, and Thermo Fisher received OpenAI's GPT-Rosalind vertical reasoning model as a research preview for drug discovery and genomics work.
Novo Nordisk
Novo Nordisk partnered with OpenAI to overhaul drug development, with pilots starting immediately in R&D, manufacturing, and commercial and full integration planned by year-end.
Operations 1 deployment
Merck
Merck committed up to $1B to Google Cloud for an enterprise AI backbone covering R&D, manufacturing, commercial, and corporate functions.
Every entry names the organisation and links its source. Outcome figures are quoted as reported, never estimated. Vendor announcements without a named customer are excluded. Halted and reversed deployments are kept on purpose.